Kulka P J, Tryba M, Sczepanski U, Zenz M
Klinik für Anaesthesiologie, Intensiv- und Schmerztherapie, Berufsgenossenschaftliche Krankenanstalten, Bergmannsheil, Universitätsklinik Bochum.
Anaesthesist. 1993 Sep;42(9):630-7.
The administration of alpha 2-adrenoceptor agonists before the induction of anaesthesia leads to a significant reduction in the amount of anaesthetic medication required, probably due to an attenuation of haemodynamic stress responses in centrally mediated sympathicolysis. However, it is not yet known whether alpha 2-adrenoceptor agonists influence the hypnotic action of anaesthetics. Therefore, this study was performed to evaluate the influence of the alpha 2-adrenoceptor agonist clonidine on the potency and the duration of the hypnotic action of anaesthetic agents. METHOD. The study was approved by the local ethical committee. To study the effect of clonidine on the potency of propofol we determined the ED50 of propofol with and without clonidine pretreatment. To this end, 100 unpremedicated patients (ASA I or II) were randomly assigned to receive 4 micrograms/kg body weight clonidine or placebo, each of which was dissolved in 100 ml NaCl and infused over a period of 15 min starting 30 min before the induction of anaesthesia. According to the results of a pilot study, patients who had been treated with clonidine received either 0.25, 0.5, 0.75, 1 or 1.25 mg/kg propofol for anaesthesia induction. Patients in the placebo group received 0.5, 1, 1.5, 2 or 2.5 mg/kg propofol. The success of anaesthesia induction was evaluated clinically (eye opening on command, eyelid reflex). On the basis of these data the ED50 of propofol with and without clonidine pretreatment was calculated using the modified probit analysis according to Spearman and Kärber. The effect of clonidine on the duration of anaesthesia was compared in six groups of 10 patients each, who received 1, 1.5 or 2 mg/kg propofol for anaesthesia induction with and without prior clonidine treatment. RESULTS. In the placebo group a dose of 0.5 mg propofol per kg did not produce a hypnotic effect in any patient, while 2.5 mg propofol per kilogram of body weight was effective in all patients. In the clonidine group 0.25 mg propofol per kilogram of body weight had no hypnotic effect, while 1.25 mg propofol per kilogram of body weight was effective in all patients. Increasing the dose of propofol resulted in an increasing number of successful anaesthesia inductions in the placebo as well as in the clonidine group. According to these data, the ED50 of propofol with clonidine was calculated at 0.675 +/- 0.23 mg/kg with clonidine and 1.5 +/- 0.58 mg/kg without clonidine pretreatment. Increasing the dose of propofol did not result in a significant increase in the duration of anaesthesia (1 mg/kg: 260 +/- 114 s; 1.5 mg/kg: 270 +/- 103 s; 2 mg/kg: 295 +/- 152 s). However, premedication with clonidine almost doubled the duration of the hypnotic action of propofol (1 mg/kg: 457 +/- 239 s; 1.5 mg/kg: 501 +/- 249 s; 2 mg/kg: 582 +/- 254 s) (P < 0.01). CONCLUSION. According to these findings the administration of clonidine prior to anaesthesia induction significantly increases the potency and the duration of the hypnotic action of propofol. From our data we conclude that the influence of clonidine on the hypnotic action of anaesthetics is an important factor in the reduction of anaesthetic requirements observed after clonidine pretreatment.
麻醉诱导前给予α2肾上腺素能受体激动剂可显著减少所需麻醉药物的用量,这可能是由于中枢介导的交感神经抑制作用减弱了血流动力学应激反应。然而,α2肾上腺素能受体激动剂是否会影响麻醉药的催眠作用尚不清楚。因此,本研究旨在评估α2肾上腺素能受体激动剂可乐定对麻醉药催眠作用的效能和持续时间的影响。方法。本研究经当地伦理委员会批准。为研究可乐定对丙泊酚效能的影响,我们测定了可乐定预处理和未预处理情况下丙泊酚的半数有效量(ED50)。为此,100例未接受术前用药的患者(美国麻醉医师协会分级I或II级)被随机分为两组,分别接受4μg/kg体重的可乐定或安慰剂,二者均溶于100ml氯化钠溶液中,并在麻醉诱导前30分钟开始15分钟内输注完毕。根据一项预试验的结果,接受可乐定治疗的患者在麻醉诱导时分别给予0.25、0.5、0.75、1或1.25mg/kg丙泊酚。安慰剂组患者接受0.5、1、1.5、2或2.5mg/kg丙泊酚。通过临床评估(按指令睁眼、眼睑反射)判断麻醉诱导是否成功。根据这些数据,采用Spearman和Kärber改良的概率分析方法计算可乐定预处理和未预处理情况下丙泊酚的ED50。在六组患者中比较可乐定对麻醉持续时间的影响,每组10例,分别接受1、1.5或2mg/kg丙泊酚进行麻醉诱导,且一组接受可乐定预处理,另一组未接受。结果。在安慰剂组中,每千克体重给予0.5mg丙泊酚对任何患者均未产生催眠作用,而每千克体重给予2.5mg丙泊酚对所有患者均有效。在可乐定组中,每千克体重给予0.25mg丙泊酚无催眠作用,而每千克体重给予1.25mg丙泊酚对所有患者均有效。在安慰剂组和可乐定组中,增加丙泊酚剂量均导致成功麻醉诱导的患者数量增加。根据这些数据,可乐定预处理时丙泊酚的ED50计算为0.675±0.23mg/kg,未进行可乐定预处理时为1.5±0.58mg/kg。增加丙泊酚剂量并未导致麻醉持续时间显著延长(1mg/kg:260±114秒;1.5mg/kg:270±103秒;2mg/kg:295±152秒)。然而,可乐定预处理几乎使丙泊酚的催眠作用持续时间延长了一倍(1mg/kg:457±239秒;1.5mg/kg:501±249秒;